Yavuz Dizdar

757 total citations
27 papers, 598 citations indexed

About

Yavuz Dizdar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yavuz Dizdar has authored 27 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Yavuz Dizdar's work include Sarcoma Diagnosis and Treatment (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Advanced Radiotherapy Techniques (3 papers). Yavuz Dizdar is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Advanced Radiotherapy Techniques (3 papers). Yavuz Dizdar collaborates with scholars based in Türkiye, Germany and United States. Yavuz Dizdar's co-authors include Fulya Ağaoğlu, Emin Darendeliler, Nejat Dalay, Stefan Holdenrieder, Uğur Gezer, H. Koyuncuoǧlu, Feyza Arıcıoğlu, Bilge Bılgıç, Ümit Sayın and Harzem Özger and has published in prestigious journals such as Journal of Clinical Oncology, Clinica Chimica Acta and Pharmacology Biochemistry and Behavior.

In The Last Decade

Yavuz Dizdar

25 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yavuz Dizdar Türkiye 12 347 279 157 82 70 27 598
Yuan Yang China 13 172 0.5× 135 0.5× 60 0.4× 94 1.1× 23 0.3× 38 512
Elena Bazzoli Italy 10 202 0.6× 122 0.4× 59 0.4× 60 0.7× 60 0.9× 13 409
Paul L. Moots United States 13 144 0.4× 90 0.3× 133 0.8× 80 1.0× 141 2.0× 26 792
Ozge Ceyhan‐Birsoy United States 13 313 0.9× 135 0.5× 62 0.4× 62 0.8× 27 0.4× 31 715
Roberto Cuttano Italy 10 361 1.0× 142 0.5× 87 0.6× 79 1.0× 344 4.9× 17 810
Masaaki Kohta Japan 12 211 0.6× 127 0.5× 73 0.5× 23 0.3× 123 1.8× 48 533
Shunji Yunoue Japan 16 237 0.7× 69 0.2× 81 0.5× 88 1.1× 175 2.5× 26 733
H. Qvist Norway 8 102 0.3× 143 0.5× 87 0.6× 174 2.1× 34 0.5× 11 420
Shaunta Guha Ireland 10 319 0.9× 82 0.3× 75 0.5× 23 0.3× 55 0.8× 12 479
Hyun Min Jung United States 15 421 1.2× 259 0.9× 53 0.3× 125 1.5× 52 0.7× 26 708

Countries citing papers authored by Yavuz Dizdar

Since Specialization
Citations

This map shows the geographic impact of Yavuz Dizdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yavuz Dizdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yavuz Dizdar more than expected).

Fields of papers citing papers by Yavuz Dizdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yavuz Dizdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yavuz Dizdar. The network helps show where Yavuz Dizdar may publish in the future.

Co-authorship network of co-authors of Yavuz Dizdar

This figure shows the co-authorship network connecting the top 25 collaborators of Yavuz Dizdar. A scholar is included among the top collaborators of Yavuz Dizdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yavuz Dizdar. Yavuz Dizdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karaman, Şule, et al.. (2022). Evaluation of DNA versus collagen perception in scientific articles examining cancer and radiation therapy: implication for collagen based approaches. The European Research Journal. 9(1). 22–28. 1 indexed citations
3.
Dizdar, Yavuz. (2015). Gıda Hastalık İlişkisi: Şekerin Yeri Nedir?. DergiPark (Istanbul University). 1(2). 9–21.
4.
Bilgin, Elif, et al.. (2014). EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study. Tumor Biology. 35(11). 11647–11653. 19 indexed citations
5.
Bilgin, Elif, et al.. (2013). For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?. Asian Pacific Journal of Cancer Prevention. 14(4). 2541–2544. 5 indexed citations
6.
Vural, Pervin, et al.. (2011). The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma. Acta Odontologica Scandinavica. 70(4). 303–308. 3 indexed citations
7.
Ağaoğlu, Fulya, Yavuz Dizdar, Emin Darendeliler, et al.. (2011). Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumor Biology. 32(3). 583–588. 276 indexed citations
8.
Ağaoğlu, Fulya, et al.. (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice. 9(1). 41–51. 2 indexed citations
9.
Gezer, Uğur, et al.. (2010). Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clinica Chimica Acta. 411(19-20). 1452–1456. 40 indexed citations
10.
Ağaoğlu, Fulya, et al.. (2009). Prostat kanserinin radyoterapisinde konformal radyoterapi tekniklerinin değerlendirilmesi. 24(4). 166–171. 1 indexed citations
11.
Demir, Adalet, Mehmet Zeki Günlüoğlu, Nergiz Dağoğlu, et al.. (2009). Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax. Journal of Thoracic Oncology. 4(2). 185–192. 24 indexed citations
12.
Özger, Harzem, Levent Eralp, Berkin Toker, Fulya Ağaoğlu, & Yavuz Dizdar. (2008). [Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors].. PubMed. 41(4). 291–4. 13 indexed citations
13.
Özger, Harzem, Levent Eralp, Ata Can Atalar, et al.. (2007). [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].. PubMed. 41(3). 211–9. 11 indexed citations
14.
Kiliçaslan, İşın, et al.. (2007). Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) of the penis. International Urology and Nephrology. 40(1). 113–115. 8 indexed citations
15.
Ağaoğlu, Fulya, Merdan Fayda, Yavuz Dizdar, et al.. (2005). Primary uterine lymphoma: Case report and literature review. Australian and New Zealand Journal of Obstetrics and Gynaecology. 45(1). 88–89. 6 indexed citations
16.
Ağaoğlu, Fulya, Yavuz Dizdar, Öner Doğan, et al.. (2005). P53 overexpression in nasopharyngeal carcinoma.. PubMed. 18(5). 555–60. 24 indexed citations
17.
Yazar, Aziz, Mert Başaran, Yavuz Dizdar, et al.. (2004). Relapse of non‐Hodgkin's lymphoma confined to the corpus uteri. Australian and New Zealand Journal of Obstetrics and Gynaecology. 44(3). 273–274. 1 indexed citations
18.
Üstüner, Zeki, Mert Başaran, Talat Kırış, et al.. (2004). Skull Base Plasmacytoma in a Patient with Light Chain Myeloma. Skull base. 13(3). 167–172. 33 indexed citations
19.
Bılgıç, Bilge, et al.. (2003). Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Pathology & Oncology Research. 9(3). 201–205. 30 indexed citations
20.
Koyuncuoǧlu, H., et al.. (1992). Effects of tizanidine on morphine physical dependence: Attenuation and intensification. Pharmacology Biochemistry and Behavior. 42(4). 693–698. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026